The study by Verwer MC et al. [39] found an association between the increased serpin G1 and CD14 plasma EV protein levels and major adverse cardiovascular events in patients with severe PAD, while elevated serpin G1 plasma EV protein levels were also independently associated with major limb adverse events following SFA endarterectomy. The gene discussed is SERPING1; the disease is peripheral arterial disease.